NEW YORK (GenomeWeb News) – Amyris said today that it has received a contract from the US Department of Defense Advanced Research Projects Agency that could total around $8 million to expand the scope of its synthetic biology technology across new biological platforms and cell types.

DARPA awarded the contract in connection with its Living Foundries Program, which seeks to create the fundamental production methods and tools, technologies, and methods required to make bio-engineering better, faster, and more accurate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.